LAURUS LABS
Back to Balance Sheet
|
LAURUS LABS Last 5 Year Total Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Liabilities | ₹7,660 Cr | ₹6,968 Cr | ₹5,751 Cr | ₹3,676 Cr | ₹3,278 Cr |
What is the latest Total Liabilities ratio of LAURUS LABS ?
Year | Total Liabilities |
---|---|
Mar2023 | ₹7,660 Cr |
Mar2022 | ₹6,968 Cr |
Mar2021 | ₹5,751 Cr |
Mar2020 | ₹3,676 Cr |
Mar2019 | ₹3,278 Cr |
How is Total Liabilities of LAURUS LABS Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹7,660 Cr | 9.94 | |
Mar2022 | ₹6,968 Cr | 21.17 | |
Mar2021 | ₹5,751 Cr | 56.42 | |
Mar2020 | ₹3,676 Cr | 12.16 | |
Mar2019 | ₹3,278 Cr | - |
Compare Total Liabilities of peers of LAURUS LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LAURUS LABS | ₹23,645.9 Cr | -1.1% | 5.7% | 43.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,026.0 Cr | 0.5% | -5.7% | 55.1% | Stock Analytics | |
CIPLA | ₹114,925.0 Cr | 1.1% | -4.4% | 55.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,128.0 Cr | -0.7% | 9.4% | 21.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,109.0 Cr | 0.1% | 1.1% | 28.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹102,736.0 Cr | 6% | 2.8% | 93.1% | Stock Analytics |
LAURUS LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LAURUS LABS | -1.1% |
5.7% |
43.8% |
SENSEX | 0.2% |
-0.2% |
20.9% |
You may also like the below Video Courses